2010). Kinases catalyze the transfer of a phosphoryl group from ATP to a serine, threonine, or tyrosine residue on a protein substrate. The presence of phosphorylation on a specific amino acid can be detected in mass spectrometry-based proteomics experiments by a characteristic mass addition of 79.96633 Da. Phosphorylation is a reversible PTM and can be removed from a substrate by phosphatase enzymes. This reversible nature enables proteins to be dynamically modified to meet cellular needs. For example, cell cycle progression requires a network of phosphorylation events that temporally oscillate to activate protein substrates. Also, protein phosphorylation is the main driving force behind signal transduction.
Another widely studied PTM is ubiquitylation. Ubiquitin is a small (8.6-kDa) protein that is added to substrates via a multistep enzymatic cascade and can be removed by a class of proteins known as deubiquitinating enzymes (DUBs). To add ubiquitin to a substrate, ubiquitin is first activated by an enzyme (E1) and conjugated to a second enzyme (E2). In most cases, a ligase enzyme (E3) recognizes a substrate and complexes with it and the E2 to facilitate transfer of ubiquitin to a lysine residue on the substrate. Unlike phosphorylation and many other PTMs that are monomeric, ubiquitin can be added to a substrate in a polymeric fashion. Here, ubiquitin can serve as both modification and substrate to generate a branched structure propagated through one of its seven lysine residues. This branching adds additional layers of complexity to ubiquitin signaling. Different branching structures have been associated with specific cellular processes. The most abundant branching structure through lysine 48 on ubiquitin (K48) is commonly used to mark proteins for degradation, whereas branching through lysine 63 (K63) is associated with the DNA damage response, signaling, and trafficking of membrane proteins (Spence et al. 1995) . Because of the size of the ubiquitin, and its capacity for polymeric addition, proteomics analysis relies on indirect detection methods. Enzymatic proteolysis of lysates with trypsin leaves the two carboxy-terminal glycine residues of ubiquitin attached to lysine. Antibodies with specificity to this diglycyl-lysine residue can then be used to purify sites of lysine ubiquitylation (Emanuele et al. 2011; Kim et al. 2011; Wagner et al. 2011) , and detection of a mass addition of 114.04293 Da on lysine residues can confirm the site of ubiquitylation (Peng and Gygi 2001) . A caveat of this approach is that other modifications by ubiquitin-like proteins can also produce a diglycyl-lysine residue (e.g., neddylation). In yeast, antibody-based enrichment of diglycyl-lysine has identified more than 5500 ubiquitylation sites on 1900 proteins, revealing that at least onethird of the proteome is ubiquitylated (Swaney et al. 2013) .
The final PTM that has been well characterized in yeast is lysine acetylation. Here, lysine acetyltransferases (KATs; also known as histone acetyltransferases, HATs) catalyze the addition of an acetyl group onto lysine residues. This modification is also reversible and can be removed by lysine deacetylases (KDACs; also known as histone deacetylases, HDACs). Using mass spectrometry detection, the characteristic mass addition of 42.01056 Da on lysine can confirm the presence of acetylation. Proteomic experiments using immunoaffinity purification methods have revealed 4000 sites of lysine acetylation in yeast (Henriksen et al. 2012) . This profiling has helped illustrate roles for lysine acetylation signaling in yeast, such as mitochondrial metabolism, protein synthesis, and chromatin organization (Henriksen et al. 2012) .
PROTEOMIC METHODS
Mass spectrometry-based proteomics is a powerful approach to identify proteins modified by a particular PTM. Additionally, characteristic mass shifts in fragmentation spectra (i.e., tandem mass spectrometry [MS/MS]) often permit exact localization of the PTM to an individual amino acid within the protein. Advances in both methodology and technology have dramatically propelled the field of PTM analysis, and over the past decade, the number of PTM sites identified in a proteomics experiment has increased more than 30-fold (Ficarro et al. 2002; Peng et al. 2003; Swaney et al. 2013) . In a single proteomics experiment, researchers can now routinely identify thousands of PTMs, as well as quantify their abundance changes in response to stimuli (Olsen et al. 2006; Kim et al. 2011; Henriksen et al. 2012) . Such advancements have illustrated the breadth and diversity of modified proteins that regulate cell state, although the challenge of defining the biological function of these PTMs still remains.
Mass spectrometry experiments to characterize PTMs are often separated into single protein or global proteomics approaches. In single protein experiments, mass spectrometry is performed on peptides following isolation of a given protein of interest. This approach is useful for comprehensive identification of the variety of PTMs on a single protein; however, the success of this approach is dependent on effective isolation of the protein of interest. Two common strategies are protein-level immunoprecipitation using antibodies and introduction of a tag to the protein that can be used for purification (e.g., GST, FLAG, His-tag). Such isolation can be highly protein-specific, and thus methods for this approach are not described here.
Alternatively, using a global proteomics approach, one can obtain a cellular wide view of the PTM status of thousands of proteins at once. Here, peptides containing a single PTM type (e.g., phosphorylation) are isolated from a complex mixture of thousands of peptides. Methods to isolate modified peptides largely fall into two categories. First are biochemical-based methods, which exploit differences in chemical properties between modified peptides and nonmodified peptides (e.g., solution charge, metal affinity). This approach is used to isolate phosphopeptides by immobilized metal affinity chromatography (IMAC); see Protocol: Enrichment of Phosphopeptides via Immobilized Metal Affinity Chromatography (Swaney and Villén 2015a) . The second category consists of immunoaffinity enrichment methods in which antibodies with specificity toward a particular PTM of interest (e.g., acetylation, ubiquitylation, phosphotyrosine) are used to purify PTM containing peptides; see Protocol: Enrichment of Modified Peptides via Immunoaffinity Precipitation with ModificationSpecific Antibodies (Swaney and Villén 2015b) .
Phosphorylation, ubiquitylation, and acetylation represent the PTMs that are most widely studied using global proteomics methods. As mentioned, many additional PTMs exist and regulate important biological processes. However, the study of these PTMs remains a challenge, as sensitive and selective purification methods for most of them have yet to be described.
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